Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
For physicians, especially residents, the exposure to work-related trauma is not only prevalent but carries a significant risk of PTSD, a condition marked by a broad spectrum of physical and psychological symptoms.
Emergency Medicine April 16th 2024
Psychiatry Advisor
A recent JAMA Network Open study reveals Trauma Center Trauma-Sensitive Yoga as a highly acceptable and effective treatment for PTSD in women veterans, exhibiting a higher completion rate than Cognitive Processing Therapy.
Psychiatry January 24th 2024
Psych Congress Network
A Phase 2B study found that a 25mg dose of psilocybin, combined with psychotherapy, produced a significant drop in patients’ scores on the Montgomery Asberg Depression Rating Scale (MADRS) after 12 weeks. This finding underscores the potential of psilocybin-assisted therapy as a promising treatment for depression.
Psychiatry November 7th 2023
Psychiatrist.com
This double-blind, placebo-controlled trial suggests that topiramate monotherapy may be an effective treatment for civilian PTSD. Despite the decrease in total CAPS score not being statistically significant, topiramate-treated patients exhibited significant reductions in reexperiencing symptoms.
Psychiatry November 1st 2023
The recent study on topiramate’s potential role in PTSD treatment has shown that three times as many patients taking topiramate saw their PTSD symptoms decrease below the clinical threshold compared to those on placebo.
Psychiatry October 24th 2023
Discover how MDMA-assisted therapy is setting new benchmarks in PTSD treatment, offering clinically meaningful improvements and a strong safety profile.
Neurology October 3rd 2023